Wednesday, Sep 24, 2025 · SEC filings
What the smart money revealed on Sep 24
270 insider filings came in. We hid 76 planned (10b5-1) sellers and 118 people whose filings were routine, like grants and tax withholding.
4 insiders at Jasper Therapeutics (JSPR) bought $347K of stock
Roles: CEO, Director. Several insiders buying in the same few days is rare.
Prospect Capital (PSEC) CEO John Barry bought $996K
374,500 shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 6 checked quarters beat the typical stock 6 months later.
NexPoint Real Estate Finance (NREF) President James Dondero bought $946K
66,000 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 4 checked quarters beat the typical stock 6 months later.
PGIM Private Credit Fund (PGIM) Officer Stuart Parker bought $500K
20,178 shares on the open market. Not a grant or an option exercise.
Absci (ABSI) Director Menelas Pangalos bought $255K
95,785 shares on the open market. Not a grant or an option exercise.
Pattern Group (PTRN) CEO David Wright sold $123M
Not marked as a planned 10b5-1 sale. Sold 24% of the shares they held directly. Still holds 29.42M shares.
Pattern Group (PTRN) Director Daniel Gay sold $16.9M
Not marked as a planned 10b5-1 sale. Sold 61% of the shares they held directly. Still holds 829,475 shares.
McEwen (MUX) VP - Finance Jeffrey Chan sold $199K
Not marked as a planned 10b5-1 sale. Sold 85% of the shares they held directly. Still holds 2,267 shares.
Show 10 more real buys
Show 49 more real sales
13F season
Holdings as of Jun 30, 2025 were due Aug 14
74 funds have filed. 68 filed for the quarter before.
Biggest real insider buys, Sep 18–24
Open-market buys by officers and directors, filed in the 7 days up to Sep 24.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.